Log In
BCIQ
Print this Print this
 

Biosimilar betaseron

  Manage Alerts
Collapse Summary General Information
Company Zydus Cadila Group
DescriptionBiosimilar of betaseron, an interferon (IFN) beta-1b
Molecular Target Interferon (IFN) beta
Mechanism of ActionBiosimilar
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today